6533b7d3fe1ef96bd1261525
RESEARCH PRODUCT
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
Antoine ParienteFrancesco SalvoJoëlle MicallefAnnie-pierre Jonville-béraAurélie GrandvuilleminThomas Soeirosubject
AdultMale2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19 vaccines030226 pharmacology & pharmacyArticle03 medical and health sciencesPharmacovigilance0302 clinical medicineBell's palsyPhase 3 clinical trialsBell PalsymedicineType I interferonsHumansBell's palsyPharmacology (medical)Potential mechanismComputingMilieux_MISCELLANEOUSAgedCOVID-19 coronavirus disease 2019Vaccines SyntheticMessenger RNASARS-CoV-2business.industryCOVID-19Bell’s palsyMiddle Agedmedicine.diseaseVirologymRNA messenger RNA3. Good healthInterferon Type IFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessdescription
Therapies - Sous presse. Epreuves corrigees par l'auteur. Disponible en ligne depuis le mardi 13 avril 2021
year | journal | country | edition | language |
---|---|---|---|---|
2021-04-02 |